AI English summary of an SEC filing — figures as filed

Ulta Beauty said Paula Oyibo, the former Chief Financial Officer, left the Company effective June 24, 2025, and the Company entered into a Separation and Release Agreement on July 21, 2025.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Jul 25, 2025Period of report Jul 21, 2025Summary published (UTC) Oct 13, 2026

Key points

AI summary

Ulta Beauty said Paula Oyibo, the former Chief Financial Officer, left the Company effective June 24, 2025, and the Company entered into a Separation and Release Agreement on July 21, 2025.
The company said it will pay Oyibo annual base salary of $754,000 over 2 years and a lump sum payment representing her annual cash bonus for fiscal 2025 at target, or 100% of annual base salary.
Ulta Beauty said it will provide Oyibo with Company-paid health care benefits for up to 18 months upon election and outplacement services, and restrictive covenants including non-competition and non-solicitation will apply for 24 months from the separation date.
The company said receipt of severance benefits is conditioned upon Oyibo's non-revocation of a general release of claims and continued compliance with the restrictive covenants, and her outstanding unvested equity awards were forfeited in accordance with the terms of the Amended and Restated 2011 Incentive Award Plan and applicable award agreements.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Former Chief Financial Officer Departure and Separation Agreement

Ulta Beauty said Paula Oyibo, the former Chief Financial Officer, left the Company effective June 24, 2025, and the Company entered into a Separation and Release Agreement on July 21, 2025.

Source · Based on the filing body and exhibits

Severance: 2 Years of Base Salary and Target Bonus

The company said it will pay Oyibo annual base salary of $754,000 over 2 years and a lump sum payment representing her annual cash bonus for fiscal 2025 at target, or 100% of annual base salary.

Source · Based on the filing body and exhibits

Health Care Benefits and Non-Competition Obligations

Ulta Beauty said it will provide Oyibo with Company-paid health care benefits for up to 18 months upon election and outplacement services, and restrictive covenants including non-competition and non-solicitation will apply for 24 months from the separation date.

Source · Based on the filing body and exhibits

Severance Payment Conditions and Forfeiture of Unvested Equity Awards

The company said receipt of severance benefits is conditioned upon Oyibo's non-revocation of a general release of claims and continued compliance with the restrictive covenants, and her outstanding unvested equity awards were forfeited in accordance with the terms of the Amended and Restated 2011 Incentive Award Plan and applicable award agreements.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.